Fulminant hepatitis B in patients with chronic HBV infection

Journal of Gastroenterology and Hepatology (Australia)

Volumn 15, Issue SUPPL. MAY, 2000, Pages

  Tan, Kai Chah ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ALPHA INTERFERON; AMINOTRANSFERASE; FAMCICLOVIR; GANCICLOVIR; HEPATITIS B ANTIBODY; HERBACEOUS AGENT; LAMIVUDINE;

ANTIBIOTIC RESISTANCE; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE EXACERBATION; GRAFT SURVIVAL; HEPATITIS B; HUMAN; IMMUNOPROPHYLAXIS; LIVER FAILURE; LIVER TOXICITY; LIVER TRANSPLANTATION; ORGAN DONOR; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT INDICATION; VIRUS INHIBITION;

EID: 0343628891     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2000.02121.x     Document Type: Conference Paper

References (21)

1. Samuel D, Bismuth H, Mathieu D et al. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet 1991; 337: 813-15.
2. Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus related liver disease. Hepatology 1991; 13: 619-26.
3. Lavine JE, Lake JR, Ascher NL, Ferrell LD, Ganem D, Wright TL. Persistent hepatitis B virus following interferon alfa therapy and liver transplantation. Gastroenterology 1991; 100: 263-7.
4. Rakela J, Wooten RS, Batts KP, Perkins JD, Taswel HF, Krom RA. Failure of interferon to prevent recurrent hepatitis B infection in hepatic allografts. Mayo Clin. Proc. 1989; 64: 429-32.
5. Chossegros P, Pouteil-Noble C, Samuel D et al. Ganciclovir is an effective antiviral agent for post-transplantation chronic HBV infections, maintenance therapy may be required in some patients. Gastroenterology 1993; 104: A888 (Abstract).
6. Gish RG, Lau JY, Brooks L et al. Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology 1996; 23: 1.
7. Kruger M, Tillman HL, Trautwein C et al. Famciclovir treatment of hepatitis B virus recurrence after orthotopic liver transplantation: A pilot study. Hepatology 1995; 22: 219A (Abstract).
8. Singh N, Gayowski T, Wannstedt CF, Wagener MM, Marino IR. Pretransplant famciclovir as prophylaxis for hepatitis B virus recurrence after liver transplantation. Transplantation 1997; 63: 1415.
9. Samuel D, Rainer M, Alexander G et al. Liver transplantation in European patients with the hepatitis B surface antigen. N. Engl. J. Med. 1993; 329: 1841-7.
10. Grellier L, Brown D, McPhillips P, Burroughs A, Rolles K, Dusheiko G. Lamivudine prophylaxis: A new strategy for prevention of reinfection in liver transplantation for hepatitis B DNA positive cirrhosis. Hepatology 1995; 22: 224A (Abstract).
11. Gutfreund KS, Fischer KP, Tipples G et al. Lamivudine results in a complete and sustained suppression of hepatitis B virus replication in patients requiring orthotopic liver transplantation for cirrhosis secondary to hepatitis B. Hepatology 1995; 22: 328A (Abstract).
12. Grellier L, Mutmer D, Ahmed M et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 1996; 348: 1212-15.
13. Bartholomew MM, Jansen RW, Jeffers LJ et al. Hepatitis B virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 1997; 349: 20.
14. Markowitz JS, Martin P, Conrad AJ et al. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology 1998; 28: 585-9.
15. Chu CM, Sheen IS, Liaw YF. The aetiology of acute hepatitis in Taiwan: Acute hepatitis superimposed on HBsAg carrier state as the main aetiology of acute hepatitis in areas with high HBsAg carrier rate. Infection 1988; 16: 233-7.
16. O'Grady JG, Alexander GJM, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-45.
17. Bernuau J, Samuel D, Durand F et al. Criteria for emergency liver transplantation in patients with acute viral hepatitis and factor V below 50% of normal: A prospective study. Hepatology 1991; 14: 49A (Abstract).
18. Emond JC, Aran PP, Whitington PF, Broelsche CE, Baker AL. Liver transplantation in the management of fulminant hepatic failure. Gastroenterology 1989; 96: 1583-8.
19. Van Thiel DH. When should a decision to proceed with transplantation actually be made in cases of fulminant or subfulminant hepatic failure: At admission to hospital or when a donor organ is made available? J. Hepatol. 1993; 17: 1-2.
20. Huo TI, Wu JC, Sheng WY et al. Prognostic factor analysis of fulminant and subfulminant hepatic failure in an area endemic for hepatitis B. J. Gastroenterol. Hepatol. 1996; 11: 560-5.
21. Takahashi Y, Kumada H, Shimizu M et al. A multicentre study on the prognosis of fulminant viral hepatitis: Early prediction for liver transplantation. Hepatology 1994; 19: 1065-71.